Join us as we bring the year to a close by chatting with Dr Rob Lentz from Natera about how circulating tumour DNA testing can inform better treatment decisions in the clinic. We hear about the power of ctDNA alongside reference tumour informed testing and the latest data supporting it's use in GI as well as many other cancers.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör NSW Early Phase Clinical Trials Alliance (NECTA). Innehållet i podden är skapat av NSW Early Phase Clinical Trials Alliance (NECTA) och inte av, eller tillsammans med, Poddtoppen.